Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Shapu Aisi Pharmaceutical Co., Ltd. was established in 1978 and is a comprehensive pharmaceutical enterprise specializing in drug research and development, production, and operation. It was successfully listed on the A-share main board of the Shanghai Stock Exchange on July 2, 2014 (stock code: 603168). In October 2020, we successfully acquired Taizhou Obstetrics and Gynecology Hospital affiliated with Nantong University, officially entering the high-quality development of "medicine+medicine", becoming a big health enterprise with medical services, drug production and sales research as the core, focusing on ophthalmology, obstetrics and children. |
| Headquarter | Jiaxing |
| Establish Date | 7/17/2000 |
| Listed Code | 603168.SH |
| Listed Date | 7/2/2014 |
| Chairman | Yan Biao. |
| CEO | Yan Biao. |
| Website | www.zjspas.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
